Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference51 articles.
1. Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics;Agarwal;Pharmgenomics Pers Med,2014
2. Short-term effects of early switching to ranibizumab or aflibercept in diabetic macular edema cases with non-response to bevacizumab;Ashraf;Ophthalmic Surg Lasers Imaging Retina,2017
3. Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis;Babiuch;Int J Retina Vitreous,2019
4. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema;Bahrami;Graefes Arch Clin Exp Ophthalmol,2017
5. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial;Baker;JAMA,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography;Ophthalmology Science;2024-07
2. Automated classification of choroidal neovascularization, diabetic macular edema, and drusen from retinal OCT images using vision transformers: a comparative study;Lasers in Medical Science;2024-05-27
3. Machine learning and optical coherence tomography-derived radiomics analysis to predict persistent diabetic macular edema in patients undergoing anti-VEGF intravitreal therapy;Journal of Translational Medicine;2024-04-16
4. Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data;European Journal of Ophthalmology;2024-03-11
5. A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition;Colloids and Surfaces B: Biointerfaces;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3